Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

Abstract excerpt

<h4>Objectives</h4> The rapid spread of the Omicron variant (B.1.1.529) alongside evidence of a relatively rapid waning of the third dose prompted Israel to administer a fourth dose of the BNT162b2 vaccine on January 2022. Thus far, sufficient real-world evidence demonstrating the effectiveness of a fourth dose against infection and severe COVID-19 are lacking. This study examined the short-term effectiveness of a...

Topics

Open a Topic to create a Post that cites this publication.

• Bacillus and Francisella bacterial research
• COVID-19 Clinical Research Studies
• Immune responses and vaccinations
• Respiratory viral infections research
• SARS-CoV-2 and COVID-19 Research
• SARS-CoV-2 detection and testing
• Vaccine Coverage and Hesitancy
• Viral gastroenteritis research and epidemiology

Identifiers and source

Literature Corpus work

cee5e8da-5820-5c70-83ef-47ae4a60f5de

DOI

10.1101/2022.03.24.22272835